Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ZITUVIO safely and effectively. See full prescribing information for ZITUVIO. ZITUVIO® (sitagliptin) tablets, for oral useInitial U.S. Approval: 2006
Medication labelWhy this: Advisory · dailymed-prescription
ZITUVIO ® is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use ZITUVIO is not recommended in patients with type 1 diabetes mellitus. ZITUVIO has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using ZITUVIO. [see Warnings and Precautions (5.1)].
- generic_name
- sitagliptin
- product_names
- Sitagliptin
- ndc
- 70710-1240, 70710-1241, 70710-1242, 70710-1240-9, 70710-1240-3, 70710-1241-3, 70710-1241-9, 70710-1242-3, 70710-1242-9
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en